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Background: The individual genetic variations, as a response to diet, have recently caught the attention of several
researchers. In addition, there is also a trend to assume food containing beneficial substances, or to supplement
food with specific compounds. Among these, there is the conjugated linoleic acid (CLA), which has been
demonstrated to reduce fat mass and to increase lean mass, even though its mechanism of action is still not
known. We investigated the effect of CLA isomers (CLA c9,t11 and CLA t10,c12) on the proteomic profile of liver,
adipose tissue, and muscle of mouse, with the aim of verifying the presence of a modification in fat and lean mass,
and to explore the mechanism of action.
Methods: C57/BL6 mice were fed for 2 months with different diets: (1) standard chow, (2) CLA c9,t11 diet, (3) CLA
t10,c11 diet, (4) CLA isomers mixture diet, and (5) linoleic acid diet. The proteomic profile of liver, white adipose
tissue, and muscle was investigated. Statistical significance of the spots with an intensity higher than twofold in
expression compared to the control was tested using student’s t test (two-tail).
Results: We found that both isomers modulate the proteomic profiles of liver, adipose tissue, and muscle by
different mechanisms of action. Liver steatosis is mostly due to the isomer CLA t10,c12, since it alters the expression
of lipogenetic proteins; it acts also reducing the adipose tissue and increasing fatty acid oxidation in muscle.
Conversely, CLA c9,t11 has no relevant effects on liver and adipose tissue, but acts mostly on muscle, where it
enhances muscular cell differentiation.
Conclusions: Administration of CLA in humans has to be carefully personalized, since even considering the
presence of a species-specific effect, adverse effects might occur on long-term supplementation. Here we
demonstrated that, in mouse, CLA is effective in reducing fat mass, but it also induces liver steatosis. The increase of
lean mass is linked to an induction of cell proliferation, which, on long-term supplementation, might also lead to
adverse effects.Background
The individual genetic variations, as a response to diet,
have recently caught the attention of several re-
searchers leading to an impressive growth of the nutri-
genomic field. The term nutrigenomic, in fact, refers to
the associations between specific nutrients and genetic
factor and in particular the way in which foods and
food ingredients can influence the response to diet. The* Correspondence: anna.iannone@unimore.it
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the level of single nucleotide polymorphisms rather
than at the gene level [6].
In the last 10 years, there is a trend to assume food
directly containing beneficial substances or to supple-
ment food with specific compounds that naturally occur
in milk and meat and, among these, conjugated linoleic
acid (CLA) plays an important role. CLA is a mixture of
positional and geometrical isomers of linoleic acid, with
two conjugated unsaturated double bonds at various car-
bon positions in the fatty acid (FA) chain. Two major
forms of CLA are CLA c9,t11 and CLA t10,c12, and a
mixture of them has been used in most of the publishedle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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the most important dietary sources are dairy products
and other foods derived from ruminants animals [7]. In
fact, CLA originates from two sources: one source is
CLA formed during ruminal biohydrogenation of lino-
leic acid; the other source is CLA synthesized by the ani-
mal’s tissues from vaccenic acid, another intermediate in
the biohydrogenation of unsaturated fatty acids.
Nowadays, CLA is supplemented in ruminants fodder,
not to improve meat quality but to obtain a milk rich in
CLA, optimizing the presence of bio-active substances
in the lipid fraction. Recently, CLA is also used in gyms
as a supplement, in order to quickly obtain a good
shape, since it is known that CLA is able to reduce fat
body mass, significantly increasing the capacity of resist-
ance to physical effort.
It has been already demonstrated that diet containing
CLA reduced the amount of adipose fat in several
species including rat, pig, hamster, chicken, and mouse
[16]. Several studies suggest that CLA t10,c12 supple-
mentation is able to reduce fat mass in mice and this is
associated to a several-fold increase in the amount of fat
stored in liver [8, 26].
In the present study, we, as well as others, have found
that CLA had a steatosic effect in mice fed with different
diets, containing 1 % CLA t10,c12 isomer, 1 % CLA
c9,t11 isomer, and a 50:50 mixture of them. None of the
published reports has used the proteomic approach to
investigate the mechanism of action involved in such
lipogenetic/lipolitic effect. We have simultaneously ex-
plored the proteome of liver and white adipose tissue
(WAT), in order to consider the possibility that a CLA-
containing diet may alter lipid metabolism through a
modulation of proteins expression.
Methods
Animals and feeding protocols
For this study, 25 adult male C57/BL6 mice (Harlan Italy
S.r.l., Udine, Italy), weighing 100–120 g, were kept in
air-conditioned colony room (temperature 21 ± 1 °C,
humidity 50 %) on a natural light-dark cycle and allowed
diet and water ad libitum. Housing conditions and
experiments were approved by the local Ethical Commit-
tee and by the Italian Ministry of Health (prot. # 121,
followed by a modification, prot. # 38). The animals
were acclimatized to our housing conditions for a week
before being fed with different diets. For this purpose,
they were divided into five groups receiving the follow-
ing diets: control group (5 mice) fed with a repelletted
purified complete 4RF21 chow; CLA c9,t11 group (5
mice) fed with a 1 % CLA c9,t11 isomer; CLA t10,c12
group (5 mice) fed with a 1 % CLA t10,c12 isomer; CLA
mix group (5 mice) fed with a 1 % of a CLA isomer
mixture of c9,t11 and t10,c12 (approx. 50:50); andlinoleic acid group (5 mice) fed with a 1 % linoleic acid.
The dietary treatments were carried out for a 60-day
period. All diets were purchased from Mucedola S.r.l.,
Settimo Milanese, Italy; CLA and CLA isomers were
from NV-CHEK-PREP, INC (Elysian, MN, USA). The
animals were kept in fasting conditions until the sacri-
fice. The mice were anesthetized by diethyl ether inhal-
ation and after beheading, liver, muscle, and WAT were
collected and immediately frozen in liquid nitrogen for
proteomic and western blotting analysis. Additionally,
hematoxylin and eosin staining was used to investigate
the liver histopathology.
Proteomic analysis
Proteomic analysis has been performed on liver, muscle,
and WAT of all the animals, and each sample was
analyzed twice. Tissues (about 150 mg) were crushed to
frozen powder by using a pestle under cooling in liquid
nitrogen. The powder was incubated for 30 min. at 4 °C in
300 ml of extraction buffer (6 M urea, 2 M thiourea, 4 %
CHAPS, 25 mM DTT, 0.2 % ampholytes), containing a
protease inhibitor cocktail (Roche Complete EDTA-free,
Roche Diagnostic, Milan). Samples were sonicated at 4 °C
in rehydratation buffer (10 s/cycle, 3 cycles) for improving
cell lysis and then centrifuged at 13,000×g for 1 h at 4 °C.
The supernatant was collected, and sample concentration
was estimated by Bio-Rad Protein Assay (Bio Rad, Hercules,
CA, USA).
For isoelectric focusing (IEF), a total of 120 mg of
proteins in rehydratation buffer with a final volume of
300 ml and trace of BPB were used in each IPG strips
(17 cm, pH 3–10 NL). The strip rehydratation was
performed for 12 h at 20 °C with a constant voltage
(50 V) in Protean IEF Cell from Bio-Rad, and the
isoelectric focusing was carried out by rapidly increasing
the voltage until 250 V for 15 min, then linearly increasing
the voltage from 250 to 10,000 V for the next 3 h; after
that, focusing was continued at 10,000 V until 75,000 V/h
and the temperature was maintained at 20 °C. After IEF,
the IPG strips were equilibrated in a buffer containing 1 %
m/v DTT by gentle shaking for 15 min. The proceedings
were repeated with equilibration buffer containing 2.5 %
m/v iodoacetamide (IAA).
The strips were applied on 12.5 % polyacrylamide gels,
and SDS-PAGE was performed in a Protean Plus Dodeca
Cell (Bio Rad, Hercules, CA, USA), that guarantees the
reliability of data and reduces experimental variation.
Indeed, this analysis has been performed in duplicate for
each sample type and by the use of a electrophoretic
dodeca cell, which allows to run simultaneously 12 gels
under identical conditions, reducing the number of run
variables and improving reproducibility. The electrophor-
esis was performed in TGS running buffer (250 mM Tris,
1.92 M glycine, 1 % SDS, pH 8.3) and was carried out with
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constant 500 V at 10 °C until BPB dye marker had reached
the bottom of the gels. Proteins were visualized with a
silver-staining modified protocol compatible with protein
digestion and MS analysis (Bellei et al., [3]).Image capture and analysis
All stained gel images were captured with a calibrated
densitometer GS-800 (Bio Rad, Hercules, CA, USA) and
then analyzed with PDQuest 7.3.1, 2D Image Analysis
software program (BioRad, Hercules, CA, USA). The
quantity of protein in each spot was normalized by the
total valid spot intensity according to the manufacturer’s
instruction. Only the spots clearly showing a greater
than twofold change in expression compared with con-
trols were selected.Statistical analysis
Spots with an intensity change higher than twofold in
expression compared to the control were undergoing to
statistical analysis. Statistical significance was tested
using student’s t test (two-tail) and the level selected was
set at P < 0.05. Significantly varied protein spots were
purified and sent to CIGS (Centro Interdipartimentale
Grandi Strumenti-University of Modena and Reggio
Emilia) for mass spectrometry analysis. Student’s t testA B
ED
Fig. 1 Necroscopic analysis from mice fed with different diets. a Control m
c12 treated mice. e CLA mix (50:50) treated micewas also used to evaluate the statistical significance of
western blot data.Tryptic in-gel digestion of proteins
Spots were excised from gels with a cut end pipette tip
and transferred into a microcentrifuge tube (0.5 ml).
Briefly, the gel pieces were incubated with 200 ml of 1:1
v/v solution 30 mM potassium hexacyano-ferrate (III)
and 100 mM sodium thiosulphate in order to destain
the spots. After two washes with 100 ml of water for
15 min, 100 ml of 100 % acetonitrile was added to
restrict the gels. Proteins were reduced and alkylated
adding sequentially 50 ml of a DTT solution (10 mM
DTT in 25 mM ammonium bicarbonate) and 50 ml of a
iodoacetamide solution (55 mM iodoacetamide in
25 mM ammonium bicarbonate). After 15 min in a
Savant SpeedVac® concentrator (Thermo Fisher Scien-
tific, USA), a volume of 30 ml trypsin (Promega,
Madison WI, USA) solution (12.5 ng/μl in 25 mM
ammonium bicarbonate) was added to the spots and the
gel pieces were incubated at 4 °C for 30 min. After
tryptic digestion, the solution was removed and the
samples were incubated at 37 °C o/n in the same
solution, without trypsin. Resulting supernatants, repre-
senting peptide solution, were recovered and dried in a
SpeedVac® concentrator. Finally, 15 ml of a 5 % formicC
ice. b Linoleic acid treated mice. c CLA c9,t11 treated mice. d CLA t10,
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lysis of peptides was performed.
Mass spectrometry analysis and MS data processing
The spectrometer was an ESI-CHIP 6520 accurate mass
Q-TOF-LC/MS (Agilent). Mass spectrometry (MS) data
were automatically registered in PKL file format, ana-
lyzed, and searched with a mammalian public protein/
genome database using MASCOT MS/MS ion searchA
B
C
D
E
Fig. 2 Mice liver sections stained with Ehrlich’s hematoxylin and eosin (H&E).
Arrows indicate some lipid droplets. Control group fed with a repelletted stan
CLA c9,t11 and CLA t10, c12 isomers (b). CLA c9,t11 group fed with a 1 % by
weight of CLA t10, c12 isomer (d). Linoleic acid group fed with a 1 % by weigprogram version 2.2.06 (Matrix Science, http://www.ma
trixscience.com). Search parameters were set as follows:
species rodents; enzyme trypsin; allowance of one
missed cleavage site; carbamidomethylation as fixed
modification; peptide tolerance ±0.8 Da; MS/MS toler-
ance error of ±0.4 Da; monoisotopic mass values and
protein mass unrestricted. The score cut-off for 95 %
protein identification was set to 37. Protein identification
was repeated at least once using spots from differentThe results of staining were viewed with ×4 and ×40 magnifications.
dard chow (a). CLA mix group fed with a 1 % by weight of a mixture of
weight of CLA c9,t11 isomer (c). CLA t10, c12 group fed with a 1 % by
ht of linoleic acid (e)
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results were selected. The Micromass software (Mas-
sLynx™; version 4.1—2005) allows for the automated
selection of peptides for fragmentation (and therefore
primary structure determination) when peptide ions
above a certain detection level are recorded. Since ESI
normally produces multiply charged peptide ions,
parameters were chosen so that only multiply charged
ions were selected for sequencing by MS/MS. The
database searched was the SwissProt 2012_07 version
(536789 sequences; 190518892 residues).
Western blot analysis
Equivalent amounts (150 mg) of liver, muscle, and WAT
were pulverized using a mortar in liquid nitrogen. The
powder was dissolved in 300 ml of extraction bufferFig. 3 Effect of CLA t10, c12 on white and brown adipose tissue. White ad
with control diet (1A, 1B) and fed with CLA t10, c12 isomer (2A, 2B). Both
compared with mice fed with control diet(50 mM Tris pH 7.6, 150 mM NaCl, 1 % Triton X-100,
0,1 % SDS, 1 M PMSF) containing a protease inhibitor
cocktail (Roche Complete EDTA-free, Roche Diagnostic,
Milan) and incubated for 30 min at 4 °C. In order to
improve cell lysis, samples were sonicated at 4 °C (10 s/
cycle, 3 cycles) and then centrifuged at 13,000×g for 1 h
at 4 °C. Protein concentration was calculated using
Bio-Rad Protein Assay (Bio Rad, Hercules, CA, USA).
A total of 120 mg of proteins in loading buffer 1×
(62.5 mM Tris–HCl pH 6.8, 2 % SDS, 10 % glycerol,
0.002 % bromophenol blue) was loaded on 13 % SDS-
polyacrylamide gel, and electrophoresis was performed in
TGS buffer. After electroblotting, performed at 200 mA
for 2 h at 4 °C in transfer buffer 1× (25 mM Tris pH 8.8,
192 mM glycine, 20 % methanol), the proteins were trans-
ferred to a nitrocellulose membrane (Trans-Blot Transferipose tissue (WAT) (1) and brown adipose tissue (BAT) (2) in mice fed
WAT than BAT completely disappeared in mice fed with CLA t10, c12
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1× TBST (0.05 M Tris–HCl pH 7.4, 0.15 M NaCl, 0.1 %
Tween 20) and blocked in blocking solution (5 % milk in
1 % TBST) for 1 h at room temperature. The proteins
blocked on membrane support were then incubated
with specific antibodies: polyclonal anti-peroxisomal
acyl-coenzime A oxidase 1 (1:1000 dilution o/n, 4 °C,
Abcam ab59964), polyclonal anti-ketohexokinase
(1:100 diluition for 1 h, 4 °C, Abcam ab38281), poly-
clonal anti-galectin-3 (1: 300 dilution o/n, 4 °C, Santa
Cruz sc-19283), and monoclonal anti-β actin (1:5000
dilution for 2 h, room temperature, Santa Cruz sc-
47778) followed by 1 h incubation at room
temperature with a secondary specific anti-goat, anti-
rabbit, and anti-mouse conjugated to horseradish per-
oxidase. Anti-peroxisomal acyl-coenzime A oxidase 1
and anti-ketohexokinase were purchased from Abcam
(Cambridge, UK), while anti-β actin and anti-galectin-3
were from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Detection was carried out using chemiluminescenceA B
C D
Fig. 4 Differentially expressed proteins in liver tissue. Spot number reflects
isoelectric value (pI) are show on the image. Circles indicate proteins up-reg
sample with respect to control sample. a Control mice. b CLA c9,t11 treateblotting substrate (ECL Plus kit, Amersham Bioscences)
following the manufacturer’s instructions.
The autoradiographic slabs were captured with a
calibrated densitometer GS-800 (Bio Rad, Hercules, CA,
USA) and then analyzed with Quantity One software
(Bio Rad, Hercules, CA, USA) for densitometric analysis.
Histological analysis
The liver tissue from different mice group was fixed in
4 % formalin, embedded in paraffin, and cut into 5-
micron sections. The sections were stained with Ehrlich’s
hematoxylin and eosin (H&E). The results of staining
were viewed and photographed with an Nikon Eclips 50i
microscope (Nikon. Tokyo, Japan) using a Plan Fluor X
lens and a Nikon Digital Sight DS-L1 camera with ×4
and ×40 magnifications. In order to evaluate the steato-
sis grade, a four-grade semi-quantitative method was
used: grade 0, no or minimal steatosis (<5 %); grade 1,
≥5 % but <25 % mild steatosis; grade 2, ≥25 % but <50 %
moderate steatosis; and grade 3, ≥50 % severe steatosis.the number reported in Table 1. Molecular weight (KDa) and
ulated while squares indicate proteins down-regulated in CLA treated
d mice. c CLA t10, c12 treated mice. d CLA mix (50:50) treated mice
AB
Fig. 5 Western blot analysis of liver lysates. a Ketoexokinase and
peroxisomal acyl-coezyme A oxidase 1 expression were detected by
anti-KHK and anti-ACOX1 antibody, respectively. β-actin level was
measured as loading control. b Densitometric analysis of KHK
and ACOX1 levels; densitometric values were normalized by the
corresponding value for β-actin. (*p < 0.05; **p < 0.01)
Table 1 Proteins separated by 2-DE electrophoresis and identified by MS in liver tissue
Spota Identification (Swiss-Prot)b Genec Sequencec coverage (%) Spotd MW (KDa) Spote pI Scoref Swissg Prot access #
1 Annexin A5 (ANXA5) Anxa5 72 35.8 4.8 631 P48036
2 Ketohexokinase (KHK) Khk 61 32.8 5.8 475 P97328
3 Major urinary protein 6 (MUP6) Mup6 52 20.7 4.7 284 P02762
4 Major urinary protein 2 (MUP2) Mup2 73 20.7 4.9 227 P11589
5 Major urinary protein 2 (MUP2) Mup2 51 20.7 4.9 96 P11589
6 Glutathione S-transferase P1 (GSTP1) Gstp1 39 20.6 8.1 211 P19157
7 Bile salt sulfotransferase 2 (ST2A2) Sult2a2 10 33.3 6.9 45 P50236
8 Alanine-TRNA ligase, cytoplasmic (SYAC) Aars 1 106.9 5.4 34 Q8BGQ7
9 Peroxisomal acyl-coenzyme A oxidase 1 (ACOX1) Acox1 15 74.7 8.6 177 Q9R0H0
a2-DE gel image spot number presented in Fig. 1
bCommonly used protein name
cGene symbol
dPercentage of amino acid sequences for the identified protein
eMW and pI = molecular weight and isoelectric point of the protein
fScore = [−10 log (P)] and P is the absolute probability that the observed match between the experimental data and the database sequence is a random event,
obtained with MASCOT for all proteins listed
gSwiss-Prot primary protein accession number
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Necroscopic analysis
After animal sacrifice, the necroscopic analysis showed
that livers from CLA-fed mice were enlarged for fat ac-
cumulation (Fig. 1) and the degree of this phenomenon
was different depending on the type of diet. Steatosis
was mild in mice fed with CLA c9,t11 diet, moderate in
mice fed with CLA mix diet, and severe in mice fed with
CLA t10,c12 diet: this latter was also pale in comparison
to all the other livers. This result was supported by the
histological analysis (Fig. 2). Furthermore, in mice fed
with CLA t10,c12, both white adipose tissue (WAT) and
brown adipose tissue (BAT) completely disappeared as
shown in Fig. 3.
Liver proteomic analysis
To evaluate whether the diet with different CLA isomers
could modify proteins expression in liver tissue, we per-
formed 2-DE analysis. Liver samples from mice treated
with oleic acid were used as control, since no difference
was found in proteomic profile between mice fed with
oleic acid and mice fed with a standard chow. The ana-
lysis of control samples revealed a number of 900 spots
on each gel, 450 of which were selected for PDQuest
analysis (Fig. 4). Only the spots that were in accordance
with the selection criterion (± twofold change) and
statistically significant were excised and subjected to
ESI-Q-TOF-MS/MS. All identified proteins are reported
in Table 1. As shown in Fig. 4, in liver of mice treated
with CLA t10,c12, a modification of nine spots was ob-
served with respect to the control group. In particular,
we found the down-regulation of six proteins: major
urinary protein 6 (MUP6, spot # 3), major urinary pro-
tein 2 (MUP2, spot # 4 and 5), glutathione S-transferase
Fig. 6 2-DE images of proteins differentially expressed in white
adipose tissue (WAT). Spot number reflects the number reported
in Table 2. Molecular weight (KDa) and isoelectric value (pI) are
show on the image. Circles indicate proteins up-regulated, while
squares indicate proteins down-regulated in CLA treated sample
with respect to control sample. a Control mice. b CLA c9,t11
treated mice. c CLA mix (50:50) treated mice
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(ST2A2, spot # 7), alanine-TRNA ligase, and cytoplasmic
(SYAC, spot # 8). Three proteins have been found
up-regulated: annexin A5 (ANXA5, spot # 1), ketoexoki-
nase (KHK, spot # 2), and peroxisomal acyl-coenzyme A
oxidase 1 (ACOX1, spot # 9). Moreover, two of these
proteins, ANXA5 and KHK, were also up-regulated in
the liver of mice fed with CLA mix.
In order to confirm the result obtained by 2-DE
analysis, we performed a western blot analysis using
anti-ACOX1 and anti-KHK antibodies. As illustrated in
Fig. 5, the expression of ACOX1 and KHK normalized
by corresponding ß-actin was significantly increased in
mice treated with CLA mix and CLA t10,c12.
Adipose tissue proteomic analysis
The study of proteomic profile of WAT extracts was
performed using the same approach used for liver tissue
(2-DE, spectrometry mass analysis and western blot con-
firmation). This analysis was not carried out in mice fed
with CLA t10,c12, since no trace of adipose tissue was
found in these mice. Also in this tissue, no differences
were found between WAT proteomic profile from mice
fed with oleic acid and mice fed with control diet: as a
consequence, WAT samples from mice treated with oleic
acid were used as control. The analysis of control
samples revealed a number of 400 spots on each gel, 250
of which were selected for PDQuest analysis (Fig. 6).
Only the spots that were in accordance with the selec-
tion criterion (± twofold change) and statistically signifi-
cant were excised and subjected to ESI-Q-TOF-MS/MS
(Table 2). Figure 6 shows that CLA mix treatment causes
the down-regulation of nine proteins: indolethylamine
N-methyltransferase (INMT, spot #1), destrin (DEST,
spot # 2), glutathione S transferase theta-1 (GSTT1, spot
# 4), mitochondrial peptide methionine sulfoxide reduc-
tase (MSRA, spot # 5), endoplasmic reticulum resistant
protein 29 (ERP29, spot # 6), delta-amino levulinic acid
dehydratase (HEM2, spot # 7), actin, alpha cardiac
muscle 1 (ACTC, spot # 8), histone H2B type 1-B
(H2B1B, spot # 9), and peptidyl prolyl cistrans isomerase
C (PPIC, spot # 10). Five proteins were up-regulated:
triosephosphate isomerase (TPIS, spot #12), galectin 3
(LEG-3 spot # 13), citrate synthase, mitochondrial (CISY,
spot # 14), AP-5 complex subunit beta 1 (AP5B1, spot #
15), and elongation factor 1 alpha-1 (EF1A1, spot #16).
Table 2 Proteins separated by 2-DE electrophoresis and identified by MS in adipose tissue
Spota Identification (Swiss-Prot)b Genec Sequencec coverage (%) Spotd MW (KDa) Spote pI Scoref Swissg Prot access #
1 Indolethylamine N-methyltransferase (INMT) iNMT 40 29.5 6.0 282 P40936
2 Destrin (DEST) DSTN 41 18.4 8.2 126 Q9R0P5
3 Pyridoxal kinase (PDXK) Pdxk 26 35.0 5.9 116 Q8K183
4 Glutathione S transferase theta-1 (GSTT1) GSTT1 32 27.2 7.2 181 P30711
5 Mitochondrial peptide methionine sulfoxide
reductase (MSRA)
Msra 19 23.8 6.7 27 Q9D6Y7
6 Endoplasmic reticulum resistant protein
29 (ERP29)
Erp29 29 25.7 5.7 185 P57759
7 Delta-amino levulinic acid dehydratase (HEM2) Alad 20 36.0 6.3 263 P10518
8 Actin, alpha cardiac muscle 1 (ACTC) Actc 1 38 41.8 5.2 606 P68033
9 Histone H2B type 1-B (H2B1B) Hist1h2bb 27 13.8 10.3 67 Q64475
10 Peptidyl prolyl cistrans isomerase C (PPIC) Ppic 14 22.8 7.0 172 P30412
11 2 Amino 3 ketobutyrate CoA ligase (KBL) Goat 39 42.8 6.5 2133 O88986
12 Triosephosphate isomerase (TPIS) Tip1 70 32.2 5.6 1581 P17751
13 Galectin 3 (LEG3) Lgals3 29 27.6 8.5 500 P16110
14 Citrate synthase mitochondrial (CISY) Cs 26 49.0 8.2 293 Q9CZU6
15 AP-5 complex subunit beta 1 (AP5B1) Ap5b1 1 94.0 5.7 22 Q3TAP4
16 Elongation factor 1 alpha-1 (EF1A1) Ef1a1 29 50.1 9.1 500 P10126
a2-DE gel image spot number presented in Fig. 1
bCommonly used protein name
cGene symbol
dPercentage of amino acid sequences for the identified protein
eMW and pI = molecular weight and isoelectric point of the protein
fScore = [−10 log (P)] and P is the absolute probability that the observed match between the experimental data and the database sequence is a random event,
obtained with MASCOT for all proteins listed
gSwiss-Prot primary protein accession number
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regulation of indolethylamine N-methyltransferase
(INMT, spot #1) and pyridoxal kinase (PDXK, spot #3)
and an up-regulation of 2-amino-3-ketobutyrate coen-
zyme A ligase (KBL, spot # 11).
An anti-LEG-3 antibody was used for western blot
analysis in order to confirm the 2-DE results. As shown
in Fig. 7, the expression of LEG-3, normalized by corre-
sponding β-actin, was significantly increased in mice
treated with CLA mix.
Muscle tissue proteomic analysis
Extracts from muscle tissue were processed for prote-
omic analysis, mass spectrometry analysis, and finally for
western blot analysis, to confirm the results. Since no
differences were found between muscle proteomic
profile from mice fed with oleic acid and mice fed with
control diet, muscle samples from mice treated with
oleic acid were used as control. In each gel, 700 spots
were revealed and 420 of these selected for PDQuest
analysis. Only the spots statistically different from con-
trol were excised and subjected to ESI-Q-TOF-MS/MS.
Results from the MS analysis are reported in Table 3.
CLA c9,t11 treatment modified the expression of two
proteins, phosphoglucomutase-1 (PGM1, spot # 1) thatwas down-regulated and galectin-1 (LEG1, spot # 4) that
was up-regulated. Furthermore, the proteomic profile of
mice fed with CLA t10,c12 shows the up-regulation of
three proteins: two isoforms of fatty acid-binding pro-
tein, heart (FABPH, spots # 2 and 3) and fumarate
hydratatase, mitochondrial (FUMH, spot # 5). The
different protein expressions are also indicated in Fig. 8.
The western blot analysis, performed with an anti-
LEG1 antibody, confirmed these results (Fig. 9).Discussion
In the present study, we evaluated the proteomic profile
of liver and WAT, in order to identify a proteomic pat-
tern related to modifications that occurred after the ad-
ministration of diet supplemented with different CLA
isomers. We found differential effects using the separate
isomers in comparison to the mixture of them: in this
case, we have to take into account that in the mixture
the amount of the individual isomers is the half, being
the final concentration always 1 %. For interpretation of
data obtained through proteomic analysis, we categorized
all identified proteins into three groups: proteins disregu-
lated in liver tissue, proteins disregulated in WAT, and
proteins disregulated in muscle.
AB
Fig. 7 Western blot analysis of adipose tissue lysates. a Galectin 3
expression was detected by anti-LEG-3 antibody. β-actin level was
measured as loading control. b Densitometric analysis of galectin 3
level; densitometric value was normalized by the corresponding
value for β-actin. (*p < 0.05)
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We found an up-regulation of ketohexokinase (KHK)
in mice fed with CLA t10,c12 isomer. Fructose is me-
tabolized in the liver by fructokinase (KHK), which
uses ATP to phosphorylate fructose to fructose-1-
phosphate. Fructokinase exists in two isoforms: fructo-
kinase C and fructokinase A, where fructokinase C is
the principal isoform in liver and rapidly leads to anTable 3 Proteins separated by 2-DE electrophoresis and identified b
Spota Identification (Swiss-Prot)b Genec Sequencec co
1 Phosphoglucomutase-1 (PGM1) Pgm1 45
2 Fatty acid-binding protein, heart (FABPH) Fabp3 59
3 Fatty acid-binding protein, heart (FABPH) Fabp3 66
4 Galectin-1 (LEG1) Lgals1 31
5 Fumarate hydratase, mitochondrial (FUMH) Fh 1
a2-DE gel image spot number presented in Fig. 1
bCommonly used protein name
cGene symbol
dPercentage of amino acid sequences for the identified protein
eMW and pI = molecular weight and isoelectric point of the protein
fScore = [−10 log (P)] and P is the absolute probability that the observed match bet
obtained with MASCOT for all proteins listed
gSwiss-Prot primary protein accession numberintracellular ATP depletion; fructokinase A, instead,
metabolizes fructose slowly, without significant ATP
consumption [15]. The metabolism of fructose results
in nucleotide turnover and uric acid generation that
may have a role in inducing mitochondrial oxidative
stress and fat accumulation [20, 21]. The up-regulation
of KHK was demonstrated in mice fed with a high-fat
diet and correlates with steatosis and obesity: for this
reason, it has been proposed as an early marker of
obesity [25]. Another study shows that the metabolism
of fructose by KHK results in intracellular production
of ureic acid and that its blockade in intracellular com-
partment could inhibit the increase in fat accumulation
due to fructose [22].
In animal cells, mitochondria, as well as peroxisomes,
oxidizes long chain fatty acids via β-oxidation [28].
When cytosolic fatty acids accumulate as a conse-
quence of an impairment of oxidative capacity in
mitochondria, alternative pathways in the peroxisomes
(β-oxidation) and in microsomes (ω-oxidation) are ac-
tivated. In peroxisomal β-oxidation, ACOX-1 catalyzes
the initial oxidation of very long fatty acids to acyl-
CoA. In non-alcoholic fatty liver disease (NAFLD),
where a triglyceride accumulation in hepatocytes (hep-
atic steatosis) is present, Kohjima et al. demonstrated
that the expression of ACOX-1 was increased twofold
compared with that in the normal liver [19]. The up-
regulation of ACOX-1 with CLA t10,c12 isomer that
we observed suggested an increase in fatty acid β-
oxidation in peroxisomes.
The increase of ACOX-1 by dietary CLA has been
previously described by Belury et al. [4] as a result of its
activity on PPAR alpha [23], and in addition, it has been
shown that it undergoes peroxisomal beta oxidation
probably inducing PPAR alpha [1] and may interfere
with other peroxisomal beta oxidation substrate [14].
Major urinary protein (MUP) family members are se-
creted proteins produced predominantly from the livery MS in muscle tissue
verage (%) Spotd MW (KDa) Spote pI Scoref Swissg Prot access #
61.7 6.1 816 Q9DOF7
14.8 6.1 790 P11404
14.8 6.1 533 P11404
15.2 5.3 135 P16045
54.5 9.1 15 P97807
ween the experimental data and the database sequence is a random event,
A B
C D
Fig. 8 Differentially expressed proteins in muscle tissue. Spot number reflects the number reported in Table 3. Molecular weight (KDa) and isoelectric
value (pI) are show on the image. Circles indicate proteins up-regulated, while a square indicates proteins down-regulated in CLA treated sample with
respect to control sample. a Control mice. b CLA c9,t11 treated mice. c CLA t10, c12 treated mice. d CLA mix (50:50) treated mice
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MUPs carry small hydrophobic ligands such as phero-
mones [13, 33], while their endocrine role is less clear.
Scientists found that in addition to mediating chemical
signaling, circulatory MUP1 regulates glucose and lipid
metabolism in animals. Indeed, overexpression of
MUP1 suppresses the expression of both glucogenic
and lipogenic genes in liver [12, 35]. The role of the
other MUPs member is not well documented and
therefore requires further studies. In our experiments
we found, in mice fed with CLA t10,c12, the down-
regulation of other two members of MUP family,
MUP2 and MUP6. None of the published reports high-
lights the effects of MUP2 and MUP6 on lipidic and
glucidic metabolism; for this reason, we suggest that a
down-regulation of MUP2 and MUP6 may have a role
in the genesis of steatosis and they could be considered
as markers of steatosis.
It has to be mentioned that liver steatosis by dietary
CLA seems to be restricted to mice, since in models of
obesity in rats, such as the Zucker, that develop fattyliver, CLA has actually an opposite effect [24], probably
mediated by PPAR alpha-mediated activity [27].
Proteins disregulated in WAT
In WAT tissue, only the CLA mix treatment caused the
up-regulation of three proteins related to lipid metabo-
lisms: triosephosphate isomerase (TPIS), citrate syn-
thase, mitochondrial (CISY), and galectin 3 (LEG-3). We
suppose that the increased expression of these three pro-
teins was determined by the effect of CLA t10,c12 iso-
mer, since the CLA c9,t11 isomer did not modify the
proteomic profile of WAT tissue.
The up-regulation of TPIS was demonstrated in rat
fed with high-fat lipid diet by Saggerson [29]. In our ex-
periments, we found the up-regulation of this protein in
mice fed with CLA mix.
The acetyl-CoA, in order to be converted into fatty
acids, must leave the mitochondria as citrate, and this
reaction is operated by the CISY. Therefore, the citrate
is cleaved into acetyl-CoA and oxaloacetate. Dietary sup-
plementation with long-chain fatty monounsaturated
Fig. 9 Western blot analysis of muscle tissue lysates. a Galectin 1
expression was detected by anti-LEG-1 antibody. HSP90 level was
measured as loading control. b Densitometric analysis of galectin 1
level; densitometric value was normalized by the corresponding
value for HSP90. (**p < 0.01)
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[34]. The up-regulation of CISY, in CLA mix treated
mice, that we observed explains the increased acetyl-
CoA bioavailability for fatty acids synthesis, and there-
fore, this protein can be considered as a possible marker
of accumulation of fatty acids.
Galectin-3 is a 30-KDa lectin which has a C-terminal
carbohydrate-recognition domain and an N-terminal do-
main comprising multiple repeat sequences. Kiwaki et al.
demonstrated that adipose tissue synthesized galectin-3
and that the up-regulation of this protein might play a
role in adipose tissue growth induced by high-fat diets
[18]. In our experiments, we found the up-regulation of
this protein in mice fed with CLA mix.
Proteins disregulated in muscle
In muscle tissues analyzed, we found a disregulation of
three proteins: fatty acid-binding protein, heart (FABPH),
fumarate hydratase mitochondrial (FUMH), and galectin-
1 (LEG1).
More in detail, FABPH is a cytosolic protein belonging
to the fatty acid-binding proteins family (FABPs), small
ubiquitous proteins (~15 KDa) that have an high affinity
with very long chain fatty acid. FABPH is expressed in
cardiac and muscular tissue and it is involved in themitochondrial β-oxidation as very long chain fatty acids
and acyl-CoA intracellular transporter. Tan et al. [32]
demonstrated that FABPH may also interact with
PPARα, nuclear receptors that induced mitochondrial
and peroxisomal β-oxidation. The observed up-
regulation of FABPH with CLA t10,c12 isomer suggests
an increase in fatty acid β-oxidation in peroxisomes.
CLA t10,c12 induces also the up-regulation of FUMH,
an enzyme involved in Krebs cycles that converts fumar-
ate to malate: this could indicate an increase of lipid ca-
tabolism and a greater ATP availability in muscle tissues.
LEG1 belongs to a family of carbohydrates binding
protein and it is primarily expressed in skeletal muscle [2].
Goldring et al. demonstrated that the addiction of LEG1
to cultures of dermal fibroblasts can induce their conver-
sion into muscle cells [10, 11] and the presence of
galectin-1 in cultured medium of mesenchymal human
stem cells increases than 30 % the cells differentiation
[31]. In our experiments, the up-regulation of LEG1 by
CLA c9,t11 treatment could therefore indicate an en-
hancement in muscular cells differentiation, leading to an
increase in lean body mass. Moreover, these data may
have an important implication regarding muscle tissue re-
pair after exercise [5]. It may also explain the effect of
CLA on skeletal muscle metabolism as recently reviewed
[17].
Conclusions
The mechanism of steatogenic action of CLA is clearly
mediated by the increased expression of lipogenetic
proteins: the up-regulation of ketohexokinase correlates
with steatosis and obesity, while the up-regulation of
the peroxisomal acyl-coenzyme A oxidase-1 suggests an
increase in fatty acid β-oxidation in peroxisomes. The
down-regulation of the major urinary proteins could be
responsible for a PPAR-γ mediated lipogenesis. The
two CLA isomers have different steatogenic effect, be-
ing the most evident effect due to the CLA t10, c12
isomer. Being both the tested isomers present in com-
mercially available CLA mixture, we suggest caution in
using it as a supplement in human diet. The effect on
body lean mass seems to be exclusively due to the iso-
mer CLA c9,t11.
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